Zhang Y, Jiang J, Black RA, Baumann G, Frank SJ
451 RivasJLPalenciaTFernndezGGarcaM
Table 1 Condensed overview of the 101 evidence-based consensus statements and research priorities along with respective rating the quality-level of evidence (Quality Rating Scheme for Studies and Other Evidence, modified from Oxford Center for Evidence-Based Medicine: 1 = properly powered and conducted RCT/systematic review with meta-analysis
The role of protein phosphorylation and other kinases in the regulation of lipolysis has been reviewed in depth elsewhere (36, 95)
5 mg vial + 2 mL BAC water: Concentration = 2,500 mcg/mL 250 mcg dose = 10 units (0.1 mL) on a 100-unit insulin syringe 500 mcg dose = 20 units (0.2 mL) on a 100-unit insulin syringe Doses per vial: 20 doses at 250 mcg, or 10 doses at 500 mcg Supplies Needed (8-Week Cycle at 250 mcg/day) 3 vials BPC-157 (5 mg each) provides 60 doses, covers 56 days with margin 3 vials bacteriostatic water (30 mL each) 60 insulin syringes (2931 gauge, 100-unit) Alcohol prep pads Administration Injection Technique BPC-157 goes subcutaneous (SubQ)
Clinical Protocol Structuring: Assisting medical directors in designing defensible, fully compliant clinical offerings that leverage FDA-approved modalities rather than unapproved compounds
